Composition and antimicrobial activity of Pastinaca sativa subsp. sativa , P. sativa subsp. urens and P. hirsuta essential oils
2022
Autori:
Ušjak, LjubošDrobac, Milica
Ivanov, Marija
Soković, Marina
Milenković, Marina T.
Niketić, Marjan
Petrović, Silvana
Tip dokumenta:
Članak u časopisu (Objavljena verzija)
,
© 2022 Informa UK Limited, trading as Taylor & Francis Group.
Metapodaci
Prikaz svih podataka o dokumentuApstrakt:
Composition and antimicrobial activity of root, leaf, stem, flower and fruit essential oils from cultivated Pastinaca sativa subsp. sativa, and its two wild-growing relatives P. sativa subsp. urens and P. hirsuta (Apiaceae) were investigated. Twenty-nine hydrodistilled essential oils of plants from different localities and/or years were analysed by GC-FID and GC/MS. Dominant in root oils was myristicin (P. sativa) or apiole (P. hirsuta), in leaf and stem oils myristicin (cultivated plants) or γ-palmitolactone (wild-growing plants) and in flower and fruit oils aliphatic esters. Multivariate statistics (PCA, nMDS, UPGMA clustering) generally revealed separation of oils of investigated Pastinaca taxa and demonstrated their chemosystematic significance. One oil per each organ of all three plants (fifteen in total) was tested using microdilution method for activity against Candida tropicalis, C. parapsilosis, C. krusei, C. glabrata, C. albicans, Staphylococcus aureus, Bacillus cereus, Listeria monocytogenes, Escherichia coli, Salmonella Typhimurium and Enterobacter cloacae; MIC = 0.25–8 mg/mL, MBC(MFC) = 0.5–16 mg/mL
Ključne reči:
antimicrobial activity; essential oils; GC-FID and GC/MS; microdilution method; multivariate statistics; PastinacasppIzvor:
Journal of Essential Oil Research, 2022, 1-14Finansiranje / projekti:
- Ministarstvo nauke, tehnološkog razvoja i inovacija Republike Srbije, institucionalno finansiranje - 200007 (Univerzitet u Beogradu, Institut za biološka istraživanja 'Siniša Stanković') (RS-MESTD-inst-2020-200007)
- Ministarstvo nauke, tehnološkog razvoja i inovacija Republike Srbije, institucionalno finansiranje - 200161 (Univerzitet u Beogradu, Farmaceutski fakultet) (RS-MESTD-inst-2020-200161)
DOI: 10.1080/10412905.2022.2147675
ISSN: 1041-2905
WoS: 000891847400001
Scopus: 2-s2.0-85142937566
URI
https://www.tandfonline.com/doi/full/10.1080/10412905.2022.2147675http://radar.ibiss.bg.ac.rs/handle/123456789/5342